ENSC
Ensysce Biosciences, Inc.
Latest Form 4:Purchase$246KbyGOWER BOB G (Director) · filed Aug 18, 2026
Ensysce Biosciences, Inc. (ENSC) has 1 SEC Form 4 filing (2 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 18, 2026.
Insiders have net bought $444K over the trailing 6 months.
- Industry:Biotechnology
- CEO:D. Lynn Kirkpatrick
- Employees:9
- HQ:La Jolla, CA, US
- IPO:2018-03-14
Insider Buying
$444K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$7.8M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
GOWER BOB GFirst filing | Director | Purchase | 508,614 | $246K | Aug 18 | SEC ↗ |
GOWER BOB GFirst filing | Director | Purchase | 400,000 | $198K | Aug 18 | SEC ↗ |
Related companies
Ensysce Biosciences, Inc. is in the Healthcare sector.